These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 15925410

  • 1. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A, Lazo JS.
    Pharmacol Ther; 2005 Aug; 107(2):212-21. PubMed ID: 15925410
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimization of experimental antimitotic agents: classical and combinatorial methods.
    Gray NS.
    Prog Cell Cycle Res; 2003 Dec; 5():135-43. PubMed ID: 14593707
    [Abstract] [Full Text] [Related]

  • 5. Structure-based virtual screening approach to identify novel classes of Cdc25B phosphatase inhibitors.
    Park H, Li M, Choi J, Cho H, Ham SW.
    Bioorg Med Chem Lett; 2009 Aug 01; 19(15):4372-5. PubMed ID: 19500977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Next generation chemical proteomic tools for rapid enzyme profiling.
    Uttamchandani M, Lu CH, Yao SQ.
    Acc Chem Res; 2009 Aug 18; 42(8):1183-92. PubMed ID: 19435360
    [Abstract] [Full Text] [Related]

  • 8. Establishment of the platform for reverse chemical genetics targeting novel protein-protein interactions.
    Koga H.
    Mol Biosyst; 2006 Mar 18; 2(3-4):159-64. PubMed ID: 16880933
    [Abstract] [Full Text] [Related]

  • 9. Receptor-based virtual ligand screening for the identification of novel CDC25 phosphatase inhibitors.
    Montes M, Braud E, Miteva MA, Goddard ML, Mondésert O, Kolb S, Brun MP, Ducommun B, Garbay C, Villoutreix BO.
    J Chem Inf Model; 2008 Jan 18; 48(1):157-65. PubMed ID: 18154280
    [Abstract] [Full Text] [Related]

  • 10. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS, Player MR.
    Curr Opin Drug Discov Devel; 2004 Nov 18; 7(6):777-83. PubMed ID: 15595438
    [Abstract] [Full Text] [Related]

  • 11. Design and implementation of cell-based assays to model human disease.
    Jones JO, Diamond MI.
    ACS Chem Biol; 2007 Nov 20; 2(11):718-24. PubMed ID: 18030988
    [Abstract] [Full Text] [Related]

  • 12. Tagged library approach facilitates forward chemical genetics.
    Kim YK, Chang YT.
    Mol Biosyst; 2007 Jun 20; 3(6):392-7. PubMed ID: 17533452
    [Abstract] [Full Text] [Related]

  • 13. Novel trends in high-throughput screening.
    Mayr LM, Bojanic D.
    Curr Opin Pharmacol; 2009 Oct 20; 9(5):580-8. PubMed ID: 19775937
    [Abstract] [Full Text] [Related]

  • 14. Small-molecule kinase-inhibitor target assessment.
    Kung C, Shokat KM.
    Chembiochem; 2005 Mar 20; 6(3):523-6. PubMed ID: 15696508
    [Abstract] [Full Text] [Related]

  • 15. A scalable approach to combinatorial library design for drug discovery.
    Sharma P, Salapaka S, Beck C.
    J Chem Inf Model; 2008 Jan 20; 48(1):27-41. PubMed ID: 18052333
    [Abstract] [Full Text] [Related]

  • 16. Image-based chemical screening.
    Carpenter AE.
    Nat Chem Biol; 2007 Aug 20; 3(8):461-5. PubMed ID: 17637778
    [Abstract] [Full Text] [Related]

  • 17. Complex phenotypic assays in high-throughput screening.
    Clemons PA.
    Curr Opin Chem Biol; 2004 Jun 20; 8(3):334-8. PubMed ID: 15183333
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Natural product-like synthetic libraries.
    Thomas GL, Johannes CW.
    Curr Opin Chem Biol; 2011 Aug 20; 15(4):516-22. PubMed ID: 21684804
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.